Who is sponsoring NCT06145724?

NCT06145724 is sponsored by Columbia University.

What drugs are being tested in NCT06145724?

Interventions in NCT06145724: Maternal Sepsis Safety Bundle.

What condition does NCT06145724 study?

NCT06145724 studies Maternal Sepsis, Infections.

Is NCT06145724 still recruiting?

NCT06145724 is currently recruiting now. Last updated 21 January 2026.

Last reviewed 2026-01-21 · How we verify

NCT06145724

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)

Recruiting now NA Last updated 21 January 2026

What this trial tests

NA trial testing Maternal Sepsis Safety Bundle in Maternal Sepsis in 33,183 participants. Currently enrolling.

Timeline

1 June 2025

Primary endpoint
31 August 2026

20 September 2026

Quick facts

Lead sponsor	Columbia University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	33,183
Start date	1 June 2025
Primary completion	31 August 2026
Estimated completion	20 September 2026
Sites	4 locations across United States

Drugs / interventions tested

Maternal Sepsis Safety Bundle

Conditions studied

Maternal Sepsis — all drugs for Maternal Sepsis →
Infections — all drugs for Infections →

Sponsor

Columbia University

Who can join

Eligibility, female only, with Maternal Sepsis or Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sepsis is the second leading cause of maternal death in the U.S. Labor and postpartum are particularly vulnerable risk periods. The goal of this multi-center, multidisciplinary study is to evaluate a maternal sepsis safety bundle.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Columbia University trials

Trials by the same sponsor.

NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06145724 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Columbia University
Last refreshed: 21 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06145724.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing